Inflammation and autoimmunity in atherosclerosis
Atherosclerosis is a process whose onset can be observed even in the foetal period. A number of risk factors, such as hyperlipidaemia, hyperhomocysteinaemia, arterial hypertension, hyperuricaemia, smoking, metabolic syndrome, hypertriglyceridaemia, and diabetes, accelerate the progression of atheros...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2022-02-01
|
| Series: | Rheumatology |
| Online Access: | https://www.termedia.pl/Inflammation-and-autoimmunity-in-atherosclerosis,18,46371,1,1.html |
| _version_ | 1817987114441113600 |
|---|---|
| author | Stanislaw Surma Krzysztof J. Filipiak |
| author_facet | Stanislaw Surma Krzysztof J. Filipiak |
| author_sort | Stanislaw Surma |
| collection | DOAJ |
| description | Atherosclerosis is a process whose onset can be observed even in the foetal period. A number of risk factors, such as hyperlipidaemia, hyperhomocysteinaemia, arterial hypertension, hyperuricaemia, smoking, metabolic syndrome, hypertriglyceridaemia, and diabetes, accelerate the progression of atherosclerotic lesions leading to the development of atherosclerotic cardiovascular disease (ASCVD) [1].
Atherosclerotic cardiovascular disease is defined as coronary artery disease (CAD), cerebrovascular disease, or peripheral arterial disease of atherosclerotic origin. This disease represents the number one cause of morbidity and mortality worldwide. The number of patients with cardiovascular diseases in the world in 2019 was 523 million, while the number of deaths due to them reached 18.6 million [2]. |
| first_indexed | 2024-04-14T00:17:45Z |
| format | Article |
| id | doaj.art-1d3a1668cbb2437b8c9bdb6496fd0c43 |
| institution | Directory Open Access Journal |
| issn | 0034-6233 2084-9834 |
| language | English |
| last_indexed | 2024-04-14T00:17:45Z |
| publishDate | 2022-02-01 |
| publisher | Termedia Publishing House |
| record_format | Article |
| series | Rheumatology |
| spelling | doaj.art-1d3a1668cbb2437b8c9bdb6496fd0c432022-12-22T02:23:04ZengTermedia Publishing HouseRheumatology0034-62332084-98342022-02-016011310.5114/reum.2022.11336446371Inflammation and autoimmunity in atherosclerosisStanislaw SurmaKrzysztof J. FilipiakAtherosclerosis is a process whose onset can be observed even in the foetal period. A number of risk factors, such as hyperlipidaemia, hyperhomocysteinaemia, arterial hypertension, hyperuricaemia, smoking, metabolic syndrome, hypertriglyceridaemia, and diabetes, accelerate the progression of atherosclerotic lesions leading to the development of atherosclerotic cardiovascular disease (ASCVD) [1]. Atherosclerotic cardiovascular disease is defined as coronary artery disease (CAD), cerebrovascular disease, or peripheral arterial disease of atherosclerotic origin. This disease represents the number one cause of morbidity and mortality worldwide. The number of patients with cardiovascular diseases in the world in 2019 was 523 million, while the number of deaths due to them reached 18.6 million [2].https://www.termedia.pl/Inflammation-and-autoimmunity-in-atherosclerosis,18,46371,1,1.html |
| spellingShingle | Stanislaw Surma Krzysztof J. Filipiak Inflammation and autoimmunity in atherosclerosis Rheumatology |
| title | Inflammation and autoimmunity in atherosclerosis |
| title_full | Inflammation and autoimmunity in atherosclerosis |
| title_fullStr | Inflammation and autoimmunity in atherosclerosis |
| title_full_unstemmed | Inflammation and autoimmunity in atherosclerosis |
| title_short | Inflammation and autoimmunity in atherosclerosis |
| title_sort | inflammation and autoimmunity in atherosclerosis |
| url | https://www.termedia.pl/Inflammation-and-autoimmunity-in-atherosclerosis,18,46371,1,1.html |
| work_keys_str_mv | AT stanislawsurma inflammationandautoimmunityinatherosclerosis AT krzysztofjfilipiak inflammationandautoimmunityinatherosclerosis |